Unknown

Dataset Information

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug.


ABSTRACT:

Aims

Although substantial progress has been made in understanding of ontogeny of drug metabolism, there is still a gap of knowledge in developmental pharmacogenetics in neonates. We hypothesized that both age and pharmacogenetics might explain the developmental pattern of CYP2C19. We conducted a population pharmacokinetic-pharmacogenetic study to quantify the developmental pharmacogenetics of CYP2C19 in neonates and young infants using omeprazole as a probe drug.

Methods

Pharmacokinetic samples were collected from 51 Caucasian neonates and young infants, who were receiving omeprazole treatment. Population pharmacokinetic-pharmacogenetic analysis of omeprazole and its metabolites was performed using NONMEM.

Results

Data fitted a one-compartment parent and metabolite mo

SUBMITTER: Zhao W 

PROVIDER: S-EPMC5903239 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature